4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000228
EVP, Chief Business Officer sold 250 shares at $62.00 ($15,500)
- EVP, Chief Business Officer acquired 250 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Baroldi Joseph · EVP, Chief Business Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-05 | Exercise or conversion : show line 1 in the form 10b5-1 | +250 | $31.80 | $7,950 | 32,176 | D |
| 2025-09-05 | Sale : show line 2 in the form 10b5-1 | −250 | $62.00 | $15,500 | 31,926 | D |
| Open-market sales · 250 sh · avg $62.00 · $15,500 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-09-05 | Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −250 | 53,650 | D |
Loading xslF345X05/edgardoc.xml…